Eurobio Scientific
Develops & distributes specialty IVD tests for oncology, transplant & infectious diseases.
ALERS | PA
Overview
Corporate Details
- ISIN(s):
- FR0004054435 (+2 more)
- LEI:
- 969500IQEUEH806GE257
- Country:
- France
- Address:
- 7 AVENUE DE SCANDINAVIE, 91940 LES ULIS
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Eurobio Scientific is an integrated specialty diagnostics company focused on developing, manufacturing, and distributing in-vitro diagnostic (IVD) tests and life sciences products for clinical use. The company's core areas of expertise are transplantation, infectious diseases, and oncology. Its portfolio includes a range of molecular diagnostics technologies, such as prognostic genomic tests for cancer, reagents and software for transplant matching, and genetic tests for various illnesses. Eurobio Scientific serves laboratories and healthcare providers, offering both its own proprietary solutions, which constitute a significant portion of its revenue, and products from partner companies through its distribution network.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-24 17:40 |
Earnings Release
Eurobio Scientific : résultat du 1er semestre 2025
|
French | 270.5 KB | ||
| 2025-09-24 17:40 |
Earnings Release
EUROBIO SCIENTIFIC: RESULTS FOR THE FIRST SEMESTER OF FISCAL YEAR 2025
|
English | 276.5 KB | ||
| 2025-07-01 17:45 |
M&A Activity
Eurobio Scientific finalise l'acquisition de l'unité Sciences de la vie de Vod…
|
French | 177.0 KB | ||
| 2025-07-01 17:45 |
M&A Activity
Eurobio Scientific completes the acquisition of Life Science unit of Voden Med…
|
English | 173.7 KB | ||
| 2025-06-17 16:59 |
Major Shareholding Notification
Franchissement de seuils
|
French | 116.1 KB | ||
| 2025-05-19 19:16 |
Major Shareholding Notification
Eurobio Scientific : EB Development franchit à la hausse le seuil de 90%
|
French | 135.1 KB | ||
| 2025-05-19 19:16 |
Major Shareholding Notification
Eurobio Scientific: EB Development rises above 90% threshold
|
English | 134.8 KB | ||
| 2025-04-29 21:00 |
Report Publication Announcement
Eurobio Scientific: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2024
|
French | 610.9 KB | ||
| 2025-04-28 17:46 |
Earnings Release
Eurobio Scientific : RESULTAT ANNUEL 2024 - Croissance du cœur d’activité et dé…
|
French | 216.3 KB | ||
| 2025-04-28 17:46 |
Earnings Release
Eurobio Scientific: 2024 annual results
|
English | 231.2 KB | ||
| 2025-03-12 17:35 |
M&A Activity
EUROBIO SCIENTIFIC ÉTEND SA PRÉSENCE EN ITALIE
|
French | 131.2 KB | ||
| 2025-03-12 17:35 |
M&A Activity
EUROBIO SCIENTIFIC INCREASES ITS FOOTPRINT IN ITALY
|
English | 133.7 KB | ||
| 2025-03-04 20:03 |
Regulatory News Service
Eurobio Scientific : résiliation du contrat de liquidité
|
French | 134.6 KB | ||
| 2025-01-15 17:46 |
Report Publication Announcement
Eurobio Scientific : calendrier des publications financieres 2025
|
French | 598.6 KB | ||
| 2024-12-19 10:30 |
Declaration of Voting Results & Voting Rights Announcements
Eurobio Scientific : EB Development obtient une très large majorité du capital …
|
French | 918.1 KB |
Automate Your Workflow. Get a real-time feed of all Eurobio Scientific filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Eurobio Scientific via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-12-18 | N/A | Other | Buy | 1,000 | 15,180.00 EUR |
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
